Table 1 Overview of cervical cancer prevention, epidemiology and population demography in the Baltic States, until 2020
From: An overview of cervical cancer epidemiology and prevention in the Baltic States
| Â | Estonia | Latvia | Lithuania |
|---|---|---|---|
Cervical cancer prevention strategies | Â | Â | Â |
Cervical cancer screening | Â | Â | Â |
 Introduction of organised screening | 2006 | 2009 | 2004 |
  Organised screening implementation nationwide, since | 2006 | 2009 | 2004 |
  Target population (eligibility criteria) |   Insured by the national health insurance (until 2021) |  |  |
  Organised screening attendance, % | 46.1 (2019) | 39.7 (2019) | 53.8 (2018)a |
  Screening registry available | Yes (since 2015) | Yes (since 2009) |  |
 Screening recommendations |  |  |  |
  Primary screening test | Pap test (cytology, until 2021) HPV test (as of 2022) | Pap test (cytology)b | Pap test (cytology) |
  Invitation mode | Printed and electronic letters | Printed letter | Diverse methods (verbal invitation during the doctor’s visit, by phone/SMS, a written postal invitation) [31] |
  Screening target ages, and frequency | 30–55 years (until 2021)c 30–65 years (as of 2022) | 25–69 years | 29–59 years |
  Screening interval | 5 years | 3 years | 3 years |
 HPV vaccination |  |  |  |
  Year of implementation | 2018 | 2010 | 2016 |
  Target group adolescents | 12–14 years 2020, 12 years | 12–18 years | 11 years |
  Sex | Girls only | Girls Since 2022 gender neutral | Girls only |
HPV vaccination programme coverage (%) | 31.3% (2019) | 69.2% (2019) | NA |
 Female population demography (2019) [17] |  |  |  |
  Size of female population in screening age | 233,226 | 625,830 | 636,528 |
  Size of annual female birth cohort | 6,734 | 10,197 | 14,672 |
  Life expectancy at birth for women | 82.8 | 79.9 | 81.0 |
 Cervical cancer epidemiology (2014–2018) |  |  |  |
  Age-standardised (World Standard Population) incidence rates per 100,000 women-years | 14.4 | 15.4 | 15.3 (2014–2015) |
  Cum. inc. per 100,000 women-years by age 75 years | 1.4 | 1.5 | 1.5 (2014–2015) |
 Annual number of new cervical cancer (CC) cases | 150 | 236 | 373 (2014–2015) |
  Annual number of CC-related deaths | 62 | 114 | 189 (2018) |
  1-year relative survival, % (95% CI) | 86d | 74.6 (72.5–76.8)e | 77.4 (75.9–78.9)e |
  5-year relative survival, % (95% CI) | 67d | 51.0 (48.2–54.1)e | 56.0 (54.1–58.1)e |